Segments - Operations and Assets Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 237,577	$ 329,219
Operating income (loss)	(30,594)	(72,424)
Depreciation and amortization	26,446	27,814
Loss from investment in investees	(37)	(49)
Assets	2,169,670		$ 2,167,259
Goodwill	597,380		595,851	$ 633,874
United States
Segment Reporting Information [Line Items]
Total revenues	189,085	291,808
Ireland
Segment Reporting Information [Line Items]
Total revenues	15,846	8,462
Chile
Segment Reporting Information [Line Items]
Total revenues	15,541	16,339
Spain
Segment Reporting Information [Line Items]
Total revenues	6,110	7,109
Israel
Segment Reporting Information [Line Items]
Total revenues	4,594	1,558
Mexico
Segment Reporting Information [Line Items]
Total revenues	5,826	3,750
Other
Segment Reporting Information [Line Items]
Total revenues	575	193
Corporate
Segment Reporting Information [Line Items]
Operating income (loss)	(9,542)	(10,768)
Depreciation and amortization	0	0
Loss from investment in investees	0	0
Assets	123,813		154,224
Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	18,955	(18,108)
Depreciation and amortization	17,760	15,402
Loss from investment in investees	(37)	(49)
Assets	1,373,982		1,322,531
Goodwill	314,355		312,826
Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	(40,007)	(43,548)
Depreciation and amortization	8,686	12,412
Loss from investment in investees	0	0
Assets	671,875		690,504
Goodwill	283,025		$ 283,025
Services
Segment Reporting Information [Line Items]
Total revenues	132,368	286,599
Services | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0
Services | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	0	0
Services | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	132,368	286,599
Products
Segment Reporting Information [Line Items]
Total revenues	40,383	36,658
Products | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0
Products | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	40,383	36,658
Products | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	0	0
Transfer of intellectual property and other
Segment Reporting Information [Line Items]
Total revenues	64,826	5,962
Transfer of intellectual property and other | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0
Transfer of intellectual property and other | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	64,826	5,962
Transfer of intellectual property and other | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	$ 0	$ 0